{"title":"Vaccinology - Principles and Practice (gnv64)","uid":8791237,"size":18116775,"categoryP":"other","categoryS":"e_books","magnet":"?xt=urn:btih:fd8b52400f921435d0f48ceeec2fd7a0a0ebcf39&amp;dn=Vaccinology+-+Principles+and+Practice+%28gnv64%29&amp;tr=udp%3A%2F%2Ftracker.openbittorrent.com%3A80&amp;tr=udp%3A%2F%2Fopen.demonii.com%3A1337&amp;tr=udp%3A%2F%2Ftracker.coppersurfer.tk%3A6969&amp;tr=udp%3A%2F%2Fexodus.desync.com%3A6969","seeders":2,"leechers":1,"uploader":"gnv65","files":-1,"time":1375952812,"description":"Vaccinology: Principles and Practice \nby W. John W. Morrow, Nadeem A. Sheikh, Clint S. Schmidt and D. Huw Davies\nWiley-Blackwell | September 2012 | ISBN-10: 1405185740 | PDF | 552 pages | 17.2 mb &lt;a href=&quot;\nhttp://www.amazon.com/Vaccinology-Principles-Practice-John-Morrow/dp/1405185740&quot; rel=&quot;nofollow&quot; target=&quot;_NEW&quot;&gt;\nhttp://www.amazon.com/Vaccinology-Principles-Practice-John-Morrow/dp/1405185740&lt;/a&gt;\n\nCovering all aspects of vaccine research and development in one volume, this authoritative resource takes a comprehensive and systematic approach to the science of vaccinology focusing not only on basic science, but also on the many stages required to commercialize and navigate the regulatory requirements for human application, both in the United States and Europe.\n-    Reviews in detail the process of designing a vaccine, from the initial stages of antigen discovery to human application\n-    Includes evaluation of vaccine efficacy and safety\n-    Details clinical trial design, including regulatory requirements\n-    Discusses the emerging field of active cellular immunotherapy\nVaccinology: Principles and Practice provides an invaluable resource for clinicians, scientific and medical researchers, lecturers and postdoctoral fellows working in the field of vaccines.\n\nCONTENTS\nPart 1 Introduction\n1 Concept and Scope of Modern Vaccines, 3\nPart 2 Principles of Vaccine Design\n2 Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants, 15\n3 Antigen Processing and Presentation by MHC Class I, II, and Nonclassical Molecules, 29\n4 Understanding the Mucosal Immune System for Better Mucosal Vaccine Design, 47\n5 Immunologic Memory: T Cells in Humans, 61\n6 Immunologic Memory: B cells, 79\n7 Utility of Mouse Models in Vaccine Design and Development, 94\n8 Utility of Nonhuman Primate Models for Vaccines, 110\nPart 3 Antigen Discovery\n9 Sequence-Based Computational Approaches to Vaccine Discovery and Design, 133\n10 Antigen Discovery for Vaccines Using High-throughput Proteomic Screening Technologies, 150\n11 Phage Libraries, 168\nPart 4 Antigen Engineering\n12 Attenuated Bacterial Vaccines, 181\n13 Virus-like Particles as Antigen Scaffolds, 196\n14 Recombinant MVA vaccines: Optimization, Preclinical, and Product Development, 209\n15 Recombinant Adenoviruses for Vaccination, 224\n16 Recombinant Avipoxviruses, 237\n17 Intracellular Facultative Bacterial Vectors for Cancer Immunotherapy, 255\n18 Nucleic Acid Vaccination, 275\n19 Artificial Antigen-presenting Cells: Large Multivalent Immunogens, 286\nPart 5 Delivery Systems\n20 Transcutaneous Immunization via Vaccine Patch Delivery System, 303\n21 Needle-free Jet Injection for Vaccine Administration, 324\n22 Oral Vaccines: An Old Need and Some New Possibilities, 336\n23 Adjuvants: From Serendipity to Rational Discovery, 348\n24 Immunostimulatory Properties of Biodegradable Microparticles, 361\n25 Co-administration of Co-stimulatory Moieties, 375\n26 Toll Receptors in Relation to Adjuvant Effects, 393\nPart 6 Regulatory Considerations\n27 Regulatory Issues (FDA and EMA), 403\nPart 7 Evaluating Vaccine Efficacy\n28 Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine, 419\n29 Clinical Development Strategy: Nuts and Bolts, 441\n30 Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification, 452\nPart 8 Implementing Immunizations/Therapies\n31 Mass Immunization Strategies, 467\n32 The Role of Mathematical Models in Vaccine Development and Public Health Decision Making, 480\n33 Vaccine Safety, 509\nIndex, 525","torrent":{"xt":"urn:btih:fd8b52400f921435d0f48ceeec2fd7a0a0ebcf39","amp;dn":"Vaccinology+-+Principles+and+Practice+%28gnv64%29","amp;tr":["udp%3A%2F%2Ftracker.openbittorrent.com%3A80","udp%3A%2F%2Fopen.demonii.com%3A1337","udp%3A%2F%2Ftracker.coppersurfer.tk%3A6969","udp%3A%2F%2Fexodus.desync.com%3A6969"],"infoHash":"fd8b52400f921435d0f48ceeec2fd7a0a0ebcf39","infoHashBuffer":{"type":"Buffer","data":[253,139,82,64,15,146,20,53,208,244,140,238,236,47,215,160,160,235,207,57]},"announce":[],"urlList":[]}}